Why the study?
Does a combination of amiodarone and flecainide prevent symptomatic arrhythmia recurrences in a patient with refractory paroxysmal atrial fibrillation?
Does a combination of amiodarone and flecainide prevent symptomatic arrhythmia recurrences in a patient with refractory paroxysmal atrial fibrillation?
A combination of amiodarone and flecainide successfully maintained sinus rhythm without significant toxicity over 8 years in a patient with refractory paroxysmal atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
May support amiodarone-flecainide in refractory paroxysmal AF; hypothesis-generating and should not change practice.
Altamirano et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: